 | Up a level |
Sadlon, Angélique (2024). In Silico Models to Validate Novel Blood-Based Biomarkers. Methods in molecular biology, 2785, pp. 321-344. Springer 10.1007/978-1-0716-3774-6_20
Sadlon, Angélique; Takousis, Petros; Ankli, Barbara; Alexopoulos, Panagiotis; Perneczky, Robert (2023). Association of chronic pain with biomarkers of neurodegeneration, microglial activation and inflammation in the CSF and impaired cognitive function. (In Press). Annals of neurology Wiley 10.1002/ana.26804
Ghisla, Virginia; Chocano-Bedoya, Patricia O; Orav, Endel John; Abderhalden, Lauren A; Sadlon, Angélique; Egli, Andreas; Krützfeldt, Jan; Kanis, John A; Bischoff-Ferrari, Heike A (2023). Prospective Study of Ageing Trajectories in the European DO-HEALTH Study. Gerontology, 69(1), pp. 57-64. Karger 10.1159/000523923
Sadlon, Angélique; Ott, Martin; Kressig, Reto W (2023). Patients with geriatric syndromes and anti-amyloid therapies: lack of consideration? An exploratory analysis of the literature. Frontiers in aging neuroscience, 15(1256968), p. 1256968. Frontiers Research Foundation 10.3389/fnagi.2023.1256968
de Godoi Rezende Costa Molino, Caroline; Chocano-Bedoya, Patricia O; Sadlon, Angélique; Theiler, Robert; Orav, John E; Vellas, Bruno; Rizzoli, Rene; Kressig, Reto W; Kanis, John A; Guyonnet, Sophie; Lang, Wei; Egli, Andreas; Bischoff-Ferrari, Heike A (2022). Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH. BMJ open, 12(4), e051881. BMJ Publishing Group 10.1136/bmjopen-2021-051881
